Document is current
Any future updates will be listed below
-
Authors
Zhang, Zihui https://orcid.org/0000-0001-8002-9396
Touponse, Gavin C. https://orcid.org/0000-0001-8087-3351
Alderman, Pia J.
Yassine, Teema
Pomrenze, Matthew B. https://orcid.org/0000-0002-9032-5911
Harris, Troy W. https://orcid.org/0009-0005-3523-9382
Shank, Amei N.
Malenka, Robert C. https://orcid.org/0000-0002-5428-5211
Eshel, Neir https://orcid.org/0000-0002-5976-2013
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01MH138645)
U.S. Department of Health & Human Services | National Institutes of Health (K08MH123791)
U.S. Department of Health & Human Services | National Institutes of Health (K99 DA056573)
Brain and Behavior Research Foundation
Burroughs Wellcome Fund
Simons Foundation
Gatsby Charitable Foundation
- License Information
-
More Information
Article History
Received: 8 April 2025
Accepted: 27 January 2026
First Online: 14 February 2026
Competing interests
: R.C.M. is on the scientific advisory boards of MapLight Therapeutics, Definium Therapeutics, and Aelis Farma. N.E. is a consultant for Boehringer Ingelheim. Z.Z., G.C.T., P.J.A., T.Y., T.W.H. M.B.P. and A.N.S. declare no competing interests.
